UA95602C2
(ru)
|
2004-12-30 |
2011-08-25 |
Берингер Ингельхейм Ветмедика, Инк. |
Иммуногенная композиция цвс2 и способы приготовления такой композиции
|
US7833707B2
(en)
|
2004-12-30 |
2010-11-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Methods of overexpression and recovery of porcine circovirus type 2 ORF2
|
US7700285B1
(en)
|
2005-12-29 |
2010-04-20 |
Boehringer Ingelheim Vetmedica, Inc. |
PCV2 immunogenic compositions and methods of producing such compositions
|
US8703095B2
(en)
|
2005-07-07 |
2014-04-22 |
Sanofi Pasteur S.A. |
Immuno-adjuvant emulsion
|
JP5106398B2
(ja)
*
|
2005-09-09 |
2012-12-26 |
インターベツト・インターナシヨナル・ベー・ベー |
Pcv−2ワクチン
|
US20110180430A1
(en)
|
2005-11-04 |
2011-07-28 |
Novartis Vaccines And Diagnostics Srl |
Adjuvanted influenza vaccines including cytokine-inducing agents
|
EP2377552A3
(en)
|
2005-11-04 |
2013-05-15 |
Novartis Vaccines and Diagnostics S.r.l. |
Influenza vaccines with reduced amount of emulsion adjuvant
|
ES2420829T3
(es)
|
2005-11-04 |
2013-08-27 |
Novartis Vaccines And Diagnostics S.R.L. |
Vacunas adyuvantadas con antígeno de no virión preparadas a partir de virus de la gripe cultivados en cultivo celular
|
PL1968630T3
(pl)
*
|
2005-12-29 |
2018-08-31 |
Boehringer Ingelheim Vetmedica, Inc. |
Multiwalentne immunogenne kompozycje PCV2
|
HUE029552T2
(en)
*
|
2005-12-29 |
2017-03-28 |
Boehringer Ingelheim Vetmedica Inc |
Use of PCV2 immunogenic composition to reduce clinical symptoms in piglets
|
FR2896162B1
(fr)
|
2006-01-13 |
2008-02-15 |
Sanofi Pasteur Sa |
Emulsion huile dans eau thermoreversible
|
BRPI0708522A2
(pt)
*
|
2006-03-03 |
2011-05-31 |
Merial Ltd |
vacina de mycoplasma hyopneumoniae
|
EP2382987A1
(en)
|
2006-03-24 |
2011-11-02 |
Novartis Vaccines and Diagnostics GmbH |
Storage of influenza vaccines without refrigeration
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
JP5954921B2
(ja)
|
2006-09-11 |
2016-07-20 |
ノバルティス アーゲー |
卵を使用しないインフルエンザウイルスワクチンの作製
|
US20100136060A1
(en)
*
|
2006-11-22 |
2010-06-03 |
Boehringer Ingelheim Vetmedica, Inc. |
Methods of reducing porcine circovirus-associated disease outbreaks
|
US20110045022A1
(en)
|
2006-12-06 |
2011-02-24 |
Theodore Tsai |
Vaccines including antigen from four strains of influenza virus
|
US20100129397A1
(en)
*
|
2006-12-11 |
2010-05-27 |
Boehringer Ingelheim Vetmedica, Inc. |
Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
|
BRPI0721083A2
(pt)
*
|
2006-12-15 |
2014-02-25 |
Boehringer Ingelheim Vetmed |
Tratamento de porcos com antígeno de pcv2
|
EP1941903A1
(en)
|
2007-01-03 |
2008-07-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Prophylaxis and treatment of PRDC
|
EP1958644A1
(en)
*
|
2007-02-13 |
2008-08-20 |
Boehringer Ingelheim Vetmedica Gmbh |
Prevention and treatment of sub-clinical pcvd
|
KR102134980B1
(ko)
|
2007-04-06 |
2020-07-16 |
다케다 백신즈 인코포레이티드 |
살아있는 약독화된 바이러스를 위한 방법 및 조성물
|
EP2185191B1
(en)
|
2007-06-27 |
2012-09-12 |
Novartis AG |
Low-additive influenza vaccines
|
US20090017064A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Wyeth |
Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
US7829274B2
(en)
*
|
2007-09-04 |
2010-11-09 |
Boehringer Ingelheim Vetmedica, Inc. |
Reduction of concomitant infections in pigs by the use of PCV2 antigen
|
US20100285069A1
(en)
|
2007-10-19 |
2010-11-11 |
Mario Contorni |
Meningococcal vaccine formulations
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
ES2763395T3
(es)
*
|
2007-12-21 |
2020-05-28 |
Zoetis Services Llc |
Bacterinas tratadas térmicamente y vacunas de emulsión preparadas a partir de tales bacterinas tratadas térmicamente
|
KR20100103535A
(ko)
*
|
2007-12-31 |
2010-09-27 |
베링거잉겔하임베트메디카인코퍼레이티드 |
외래 아미노산 삽입물을 갖는 pcv2 orf2 바이러스 유사 입자
|
US20090317423A1
(en)
|
2008-01-23 |
2009-12-24 |
Boehringer Ingelheim Vetmedica, Inc. |
Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
|
EP2268309B1
(en)
|
2008-03-18 |
2015-01-21 |
Novartis AG |
Improvements in preparation of influenza virus vaccine antigens
|
EP2306812A4
(en)
*
|
2008-07-30 |
2013-02-20 |
Univ Kentucky Res Found |
EQUINE DISEASE MODEL FOR NEUROLOGICAL AUROPTIC VIRUS DISEASE AND USED ASSAYS
|
EP2331127A2
(en)
|
2008-09-18 |
2011-06-15 |
Novartis AG |
Vaccine adjuvant combinations
|
MX2011005604A
(es)
|
2008-11-28 |
2011-09-01 |
Merial Ltd |
Vacuna recombinante para influenza aviar y sus usos.
|
CA2752041A1
(en)
|
2009-02-10 |
2010-08-19 |
Novartis Ag |
Influenza vaccines with increased amounts of h3 antigen
|
EP2396030B1
(en)
|
2009-02-10 |
2015-08-12 |
Novartis AG |
Influenza vaccine regimens for pandemic-associated strains
|
DK2396032T3
(en)
|
2009-02-10 |
2016-12-19 |
Seqirus Uk Ltd |
Influenza vaccines with reduced amounts of squalene
|
CA2754618A1
(en)
|
2009-03-06 |
2010-09-10 |
Novartis Ag |
Chlamydia antigens
|
EP2228054A1
(en)
*
|
2009-03-13 |
2010-09-15 |
ITALFARMACO S.p.A. |
Riluzole aqueous suspensions
|
WO2010109324A1
(en)
|
2009-03-24 |
2010-09-30 |
Novartis Ag |
Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
|
AU2010238255B2
(en)
|
2009-04-14 |
2014-10-16 |
Novartis Ag |
Compositions for immunising against Staphylococcus aureus
|
US8524252B2
(en)
*
|
2009-05-19 |
2013-09-03 |
Bioproperties Pty Ltd. |
Temperature sensitive vaccine strain of Mycoplasma hyopneumoniae and uses thereof
|
BRPI1011171A2
(pt)
|
2009-05-21 |
2015-08-25 |
Novartis Ag |
Genética reversa usando promotores poli i não-endógeno
|
NZ596671A
(en)
|
2009-05-29 |
2013-06-28 |
Novartis Ag |
Assays for influenza virus hemagglutinins
|
MX2012000395A
(es)
|
2009-07-07 |
2012-02-28 |
Novartis Ag |
Inmunogenos conservados de escherichia coli.
|
CA2768343A1
(en)
|
2009-07-16 |
2011-01-20 |
Novartis Ag |
Detoxified escherichia coli immunogens
|
CA2762366C
(en)
*
|
2009-07-31 |
2017-09-19 |
National Research Council Of Canada |
H. pylori lipopolysaccharide outer core epitope
|
TWI627281B
(zh)
*
|
2009-09-02 |
2018-06-21 |
百靈佳殷格翰家畜藥品公司 |
降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
|
MY157607A
(en)
*
|
2009-09-10 |
2016-06-30 |
Merial Inc |
New vaccine formulations comprising saponin-containing adjuvants
|
US20120237536A1
(en)
|
2009-09-10 |
2012-09-20 |
Novartis |
Combination vaccines against respiratory tract diseases
|
GB0917003D0
(en)
|
2009-09-28 |
2009-11-11 |
Novartis Vaccines Inst For Global Health Srl |
Purification of bacterial vesicles
|
GB0917002D0
(en)
|
2009-09-28 |
2009-11-11 |
Novartis Vaccines Inst For Global Health Srl |
Improved shigella blebs
|
WO2011039631A2
(en)
|
2009-09-30 |
2011-04-07 |
Novartis Ag |
Expression of meningococcal fhbp polypeptides
|
CA2778332A1
(en)
|
2009-10-20 |
2011-04-28 |
Novartis Ag |
Improved reverse genetics methods for virus rescue
|
GB0918392D0
(en)
|
2009-10-20 |
2009-12-02 |
Novartis Ag |
Diagnostic and therapeutic methods
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
US9173954B2
(en)
|
2009-12-30 |
2015-11-03 |
Glaxosmithkline Biologicals Sa |
Polysaccharide immunogens conjugated to E. coli carrier proteins
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
EP2547357A1
(en)
|
2010-03-18 |
2013-01-23 |
Novartis AG |
Adjuvanted vaccines for serogroup b meningococcus
|
FR2957933B1
(fr)
*
|
2010-03-24 |
2012-04-27 |
Seppic Sa |
Vaccin vivant pour maladies aviaires
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
EP2556151A1
(en)
|
2010-04-07 |
2013-02-13 |
Novartis AG |
Method for generating a parvovirus b19 virus-like particle
|
WO2011136738A1
(en)
|
2010-04-30 |
2011-11-03 |
Temasek Life Sciences Laboratory Limited |
Universal vaccine against h5n1 lineages
|
PL2569007T3
(pl)
*
|
2010-05-11 |
2016-04-29 |
Intervet Int Bv |
Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki
|
CN103025350A
(zh)
|
2010-05-21 |
2013-04-03 |
诺华有限公司 |
流感病毒的重配方法
|
GB201009861D0
(en)
|
2010-06-11 |
2010-07-21 |
Novartis Ag |
OMV vaccines
|
CA2803239A1
(en)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Combinations of meningococcal factor h binding proteins
|
WO2012006293A1
(en)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Norovirus derived immunogenic compositions and methods
|
GB201017519D0
(en)
|
2010-10-15 |
2010-12-01 |
Novartis Vaccines Inst For Global Health S R L |
Vaccines
|
WO2012072769A1
(en)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Pneumococcal rrgb epitopes and clade combinations
|
WO2012117377A1
(en)
|
2011-03-02 |
2012-09-07 |
Novartis Ag |
Combination vaccines with lower doses of antigen and/or adjuvant
|
US10030052B2
(en)
|
2011-07-25 |
2018-07-24 |
Glaxosmithkline Biologicals Sa |
Parvovirus Vp1 unique region polypeptides and compositions thereof
|
ES2732708T3
(es)
|
2011-09-14 |
2019-11-25 |
Glaxosmithkline Biologicals Sa |
Procedimientos de fabricación de glucoconjugados de sacárido-proteína
|
EP2768528A1
(en)
|
2011-10-20 |
2014-08-27 |
Novartis AG |
Adjuvanted influenza b virus vaccines for pediatric priming
|
JP2016539314A
(ja)
|
2011-12-12 |
2016-12-15 |
ノバルティス アーゲー |
インフルエンザウイルス血球凝集素のためのアッセイ法
|
EP2793939A1
(en)
|
2011-12-23 |
2014-10-29 |
Novartis AG |
Stable compositions for immunising against staphylococcus aureus
|
ES2632429T3
(es)
|
2012-02-14 |
2017-09-13 |
Merial, Inc. |
Vacunas subunitarias de rotavirus y procedimientos para la fabricación y utilización de las mismas
|
AU2013205478B9
(en)
|
2012-03-02 |
2014-11-20 |
Seqirus UK Limited |
Influenza virus reassortment
|
WO2013182498A1
(en)
|
2012-06-04 |
2013-12-12 |
Novartis Ag |
Improved safety testing
|
JP2015528456A
(ja)
|
2012-08-31 |
2015-09-28 |
ノバルティス アーゲー |
Staphylococcusaureusに対する免疫化のための安定化されたタンパク質
|
DK2890394T3
(da)
|
2012-08-31 |
2019-07-15 |
Glaxosmithkline Biologicals Sa |
Stabiliserede proteiner til immunisering mod Staphylococcus aureus
|
HUE059179T2
(hu)
|
2012-09-10 |
2022-10-28 |
Galenbio Inc |
Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
|
EP2897635A1
(en)
|
2012-09-18 |
2015-07-29 |
Novartis AG |
Outer membrane vesicles
|
CN105307684A
(zh)
|
2012-10-02 |
2016-02-03 |
葛兰素史密丝克莱恩生物有限公司 |
非直链糖缀合物
|
GB201218195D0
(en)
|
2012-10-10 |
2012-11-21 |
Istituto Zooprofilattico Sperimentale Delle Venezie |
Composition
|
PL2925355T3
(pl)
|
2012-11-30 |
2018-06-29 |
Glaxosmithkline Biologicals S.A. |
Antygeny pseudomonas i połączenia antygenów
|
JP6421128B2
(ja)
|
2012-12-03 |
2018-11-07 |
ノバルティス アーゲー |
リアソータントインフルエンザaウイルス
|
AU2014229255B2
(en)
|
2013-03-13 |
2018-12-13 |
Novartis Ag |
Influenza B virus reassortment
|
WO2014182872A1
(en)
|
2013-05-08 |
2014-11-13 |
Protatek International, Inc. |
Vaccine for pcv2 and mycoplasma
|
SG11201509265SA
(en)
|
2013-05-10 |
2015-12-30 |
Novartis Ag |
Avoiding narcolepsy risk in influenza vaccines
|
DE202013005100U1
(de)
|
2013-06-05 |
2013-08-26 |
Novartis Ag |
Influenza Virus Reassortierung
|
DE202013005130U1
(de)
|
2013-06-05 |
2013-09-10 |
Novartis Ag |
Influenza Virus Reassortierung
|
MX2015016755A
(es)
|
2013-06-06 |
2016-04-13 |
Novartis Ag |
Reagrupamiento del virus de influenza.
|
EP3052516B1
(en)
|
2013-10-02 |
2020-01-01 |
Boehringer Ingelheim Animal Health USA Inc. |
Pcv2 orf2 protein variant and virus like particles composed thereof
|
WO2015082458A1
(en)
*
|
2013-12-03 |
2015-06-11 |
Intervet International B.V. |
Vaccine against porcine circo virus type 2
|
CN103751779A
(zh)
*
|
2014-02-25 |
2014-04-30 |
中国农业科学院上海兽医研究所 |
O型口蹄疫多肽的泊洛沙姆凝胶佐剂
|
RS59971B1
(sr)
|
2014-03-26 |
2020-03-31 |
Glaxosmithkline Biologicals Sa |
Mutantni stafilokokni antigeni
|
US9713639B2
(en)
|
2014-05-19 |
2017-07-25 |
Merial, Inc. |
Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV)
|
US20150359880A1
(en)
*
|
2014-06-16 |
2015-12-17 |
Biomune Company |
Dual adjuvant vaccine compositions, preparation and uses
|
CN105267963A
(zh)
*
|
2014-06-18 |
2016-01-27 |
潘皓 |
纳米乳疫苗辅剂的制备方法
|
JP2015120709A
(ja)
*
|
2015-01-09 |
2015-07-02 |
ラボラトリオ アヴィメキシコ エスエー ディーイー シーヴィーLaboratorio Avi−Mex,S.A. De C.V. |
遺伝子組み換え不活性化ウィルスベクターワクチン
|
US10617752B2
(en)
|
2015-06-26 |
2020-04-14 |
Boehringer Ingelheim Animal Health USA Inc. |
Inactivated canine influenza vaccines and methods of making and uses thereof
|
US11013795B2
(en)
|
2015-06-26 |
2021-05-25 |
Seqirus UK Limited |
Antigenically matched influenza vaccines
|
CA2990745A1
(en)
|
2015-07-07 |
2017-01-12 |
Seqirus UK Limited |
Influenza potency assays
|
CA3001340A1
(en)
|
2015-10-08 |
2017-04-13 |
Merial, Inc. |
Live attenuated heterologous vaccine for leptospira
|
CA3006078A1
(en)
|
2015-11-23 |
2017-06-01 |
Merial, Inc. |
Fmdv and e2 fusion proteins and uses thereof
|
TWI760322B
(zh)
|
2016-01-29 |
2022-04-11 |
美商百靈佳殷格翰動物保健美國有限公司 |
重組腺病毒載體裝載之fmdv疫苗及其用途
|
JOP20190088A1
(ar)
|
2016-10-21 |
2019-04-21 |
Us Agriculture |
نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
|
BR112019010394A2
(pt)
*
|
2016-11-29 |
2019-09-03 |
Intervet Int Bv |
vacina suína
|
KR20230170803A
(ko)
|
2016-12-14 |
2023-12-19 |
뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 |
조류 병원체의 다중 항원을 발현하는 재조합 hvt 벡터 및 그를 포함하는 백신
|
FR3092754B1
(fr)
*
|
2019-02-18 |
2022-06-03 |
Total Marketing Services |
Composition adjuvante pour vaccin
|
WO2021099419A1
(en)
|
2019-11-18 |
2021-05-27 |
Seqirus UK Limited |
Method for producing reassortant influenza viruses
|
CN113546162B
(zh)
*
|
2021-05-31 |
2023-07-18 |
江苏省农业科学院 |
一种支原体疫苗及其制备方法
|